Novavax Covid-19 shot shows 90% efficacy, Serum Institute starts production
US dependent Novavax on Monday mentioned that its nano-particle protein dependent Covid-19 vaccine applicant has
efficacy
AstraZeneca vaccine shows 79% efficacy in phase III trial
(Picture by Halfpoint Illustrations or photos/Getty Illustrations or photos) AstraZeneca’s COVID-19 vaccine has just undergone